-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Awf61CSqjFf4t3aO8He5ggEbaXuOZ4+okjJZZ8182nq1rU+hXNLwNWdlR9W9XrBz mN0Gaq9mrU3DwVTxPUZV/Q== 0000950135-03-006074.txt : 20031217 0000950135-03-006074.hdr.sgml : 20031217 20031217162624 ACCESSION NUMBER: 0000950135-03-006074 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031217 ITEM INFORMATION: Other events FILED AS OF DATE: 20031217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALKERMES CLINICAL PARTNERS LP CENTRAL INDEX KEY: 0001000688 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043145043 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26758 FILM NUMBER: 031060296 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940171 8-K 1 b48813cpe8vk.txt ALKERMES CLINICAL PARTNERS, L.P. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 DATE OF REPORT - DECEMBER 17, 2003 (Date of earliest event reported) ALKERMES CLINICAL PARTNERS, L.P. (Exact name of Registrant as specified in its charter) DELAWARE 0-26758 043-145043 (State of organization) (Commission file number) (IRS employer identification number) 88 SIDNEY STREET, CAMBRIDGE, MASSACHUSETTS 02139 (Address of principal executive offices, zip code) AREA CODE (617) 494-0171 (Telephone number) ITEM 5. OTHER EVENTS. The Limited Partners of Alkermes Clinical Partners, L.P. met today and approved the termination of Alkermes Clinical Partners, L.P. SIGNATURES Pursuant to requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: December 17, 2003 Alkermes Clinical Partners, L.P. By: /s/ James M. Frates ---------------------------------------- James M. Frates Chief Financial Officer, Vice President, Treasurer and Assistant Secretary -----END PRIVACY-ENHANCED MESSAGE-----